Corrigendum to "The efficacy and safety of remimazolam tosilate compared with propofol for endoscopic retrograde cholangiopancreatography under monitored anesthesia care: A single-center randomized controlled clinical trial" [Heliyon Volume 10, Issue 19, October 2024, Article e38349]
- PMID: 40535287
- PMCID: PMC12134672
- DOI: 10.1016/j.heliyon.2025.e43275
Corrigendum to "The efficacy and safety of remimazolam tosilate compared with propofol for endoscopic retrograde cholangiopancreatography under monitored anesthesia care: A single-center randomized controlled clinical trial" [Heliyon Volume 10, Issue 19, October 2024, Article e38349]
Abstract
[This corrects the article DOI: 10.1016/j.heliyon.2024.e38349.].
© 2025 The Author(s).
Conflict of interest statement
The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.
Erratum for
-
The efficacy and safety of remimazolam tosilate compared with propofol for endoscopic retrograde cholangiopancreatography under monitored anesthesia care: A single-center randomized controlled clinical trial.Heliyon. 2024 Sep 24;10(19):e38349. doi: 10.1016/j.heliyon.2024.e38349. eCollection 2024 Oct 15. Heliyon. 2024. PMID: 39391505 Free PMC article.
Publication types
LinkOut - more resources
Full Text Sources
